BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23255545)

  • 1. Treatment planning optimisation in proton therapy.
    McGowan SE; Burnet NG; Lomax AJ
    Br J Radiol; 2013 Jan; 86(1021):20120288. PubMed ID: 23255545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust optimization of intensity modulated proton therapy.
    Liu W; Zhang X; Li Y; Mohan R
    Med Phys; 2012 Feb; 39(2):1079-91. PubMed ID: 22320818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
    An Y; Liang J; Schild SE; Bues M; Liu W
    Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations for shoot-through FLASH proton therapy.
    Verhaegen F; Wanders RG; Wolfs C; Eekers D
    Phys Med Biol; 2021 Mar; 66(6):06NT01. PubMed ID: 33571981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Proton Treatment Planning: Physical and Biological Optimization.
    Unkelbach J; Paganetti H
    Semin Radiat Oncol; 2018 Apr; 28(2):88-96. PubMed ID: 29735195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust mixed electron-photon radiation therapy optimization.
    Renaud MA; Serban M; Seuntjens J
    Med Phys; 2019 Mar; 46(3):1384-1396. PubMed ID: 30628079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and robustness of dose painting by numbers in proton therapy with contour-driven plan optimization.
    Barragán AM; Differding S; Janssens G; Lee JA; Sterpin E
    Med Phys; 2015 Apr; 42(4):2006-17. PubMed ID: 25832091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton therapy - Present and future.
    Mohan R; Grosshans D
    Adv Drug Deliv Rev; 2017 Jan; 109():26-44. PubMed ID: 27919760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical robustness evaluation in radiotherapy - A photon and proton-proof alternative to PTV-based plan evaluation.
    Korevaar EW; Habraken SJM; Scandurra D; Kierkels RGJ; Unipan M; Eenink MGC; Steenbakkers RJHM; Peeters SG; Zindler JD; Hoogeman M; Langendijk JA
    Radiother Oncol; 2019 Dec; 141():267-274. PubMed ID: 31492443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Robust treatment planning in proton therapy].
    Sterpin E; Barragan A; Souris K; Lee JA
    Cancer Radiother; 2016 Oct; 20(6-7):523-9. PubMed ID: 27614528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study.
    Flynn RT; Barbee DL; Mackie TR; Jeraj R
    Phys Med Biol; 2007 Oct; 52(20):6073-91. PubMed ID: 17921573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of robust optimization in intensity-modulated proton therapy with different dose delivery techniques.
    Liu W; Li Y; Li X; Cao W; Zhang X
    Med Phys; 2012 Jun; 39(6):3089-101. PubMed ID: 22755694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties.
    Park PC; Zhu XR; Lee AK; Sahoo N; Melancon AD; Zhang L; Dong L
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e329-36. PubMed ID: 21703781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A robust optimisation approach accounting for the effect of fractionation on setup uncertainties.
    Lowe M; Aitkenhead A; Albertini F; Lomax AJ; MacKay RI
    Phys Med Biol; 2017 Oct; 62(20):8178-8196. PubMed ID: 28901947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
    Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
    Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured.
    Noble DJ; Ajithkumar T; Lambert J; Gleeson I; Williams MV; Jefferies SJ
    Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):439-447. PubMed ID: 28318880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.
    Gordon JJ; Sayah N; Weiss E; Siebers JV
    Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of proton therapy and IMRT treatment plans for prostate radiotherapy.
    Dowdell SJ; Metcalfe PE; Morales JE; Jackson M; Rosenfeld AB
    Australas Phys Eng Sci Med; 2008 Dec; 31(4):325-31. PubMed ID: 19239059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.